JACK A ELIAS, MD
Osteopathic Medicine in New Haven, CT
License number
Connecticut 030931
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Connecticut 030931
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
789 Howard Ave Fitkin Building - FLOOR 2ND, New Haven, CT 06519
Phone
(203) 785-4198
(203) 785-3826 (Fax)
(203) 785-3826 (Fax)
Personal information
See more information about JACK A ELIAS at radaris.comName
Address
Phone
333 Cedar St, New Haven, CT 06510
New Haven, CT
64 Old Quarry Rd, Woodbridge, CT 06525
333 Cedar St, New Haven, CT 06510
Organization information
See more information about JACK A ELIAS at bizstanding.comJack Elias MD
789 Howard Ave, New Haven, CT 06519
Industry:
Allergist, Internist
Phone:
(203) 785-4198 (Phone)
Jack Angel Elias
Yale Pulmonary-Critical Care - Jack A Elias MD
789 Howard Ave, New Haven, CT 06519
Categories:
Pulmonary & Respiratory Physicians & Surgeons
Phone:
(203) 785-4198 (Phone)
Yale Pulmonary Medicine - Jack A Elias MD
333 Cedar St #105LCI, New Haven, CT 06510
Categories:
Physicians & Surgeons, Pulmonary & Respiratory Physicians & Surgeons
Phone:
(203) 785-4162 (Phone)
Professional information
See more information about JACK A ELIAS at trustoria.com
Jack A Elias, New Haven CT
Jack A Elias, New Haven CT
Specialties:
Internist
Address:
789 Howard Ave, New Haven, CT 06519
300 George St, New Haven, CT 06511
333 Cedar St, New Haven, CT 06510
300 George St, New Haven, CT 06511
333 Cedar St, New Haven, CT 06510
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
Hospital of the University of Pennsylvania - Residency - Internal Medicine
Hospital of the University of Pennsylvania - Residency - Internal Medicine
Board certifications:
American Board of Allergy and Immunology Certification in Allergy and Immunology, American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Dr. Jack A Elias, New Haven CT - MD (Doctor of Medicine)
Dr. Jack A Elias, New Haven CT - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
1 Gilbert St, New Haven 06519
YALE UNIVERSITY SCHOOL OF MEDICIN
789 Howard Ave SUITE 2ND, New Haven 06519
(203) 785-6359 (Phone), (203) 785-3826 (Fax)
YALE UNIVERSITY SCHOOL OF MED
1 Gilbert St SUITE S460, New Haven 06519
(203) 785-5585 (Phone)
YALE UNIVERSITY SCHOOL OF MEDICINE
300 Cedar St, New Haven 06519
(203) 785-4162 (Phone)
YALE UNIVERSITY SCHOOL OF MEDICIN
789 Howard Ave SUITE 2ND, New Haven 06519
(203) 785-6359 (Phone), (203) 785-3826 (Fax)
YALE UNIVERSITY SCHOOL OF MED
1 Gilbert St SUITE S460, New Haven 06519
(203) 785-5585 (Phone)
YALE UNIVERSITY SCHOOL OF MEDICINE
300 Cedar St, New Haven 06519
(203) 785-4162 (Phone)
Certifications:
Allergy & Immunology, 1981, Critical Care Medicine, 1991, Internal Medicine, 1979, Pulmonary Disease, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1 Gilbert St, New Haven 06519
YALE UNIVERSITY SCHOOL OF MED
1 Gilbert St SUITE S460, New Haven 06519
YALE UNIVERSITY SCHOOL OF MEDICINE
300 Cedar St, New Haven 06519
YALE UNIVERSITY SCHOOL OF MEDICIN
789 Howard Ave SUITE 2ND, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510
YALE UNIVERSITY SCHOOL OF MED
1 Gilbert St SUITE S460, New Haven 06519
YALE UNIVERSITY SCHOOL OF MEDICINE
300 Cedar St, New Haven 06519
YALE UNIVERSITY SCHOOL OF MEDICIN
789 Howard Ave SUITE 2ND, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Perelman School of Medicine University of Pennsylvania
Graduated: 1976
Tufts New England Medical Center
Hospital Of The University Of Pennsylvania
Perelman School of Medicine University of Pennsylvania
Graduated: 1976
Tufts New England Medical Center
Hospital Of The University Of Pennsylvania
Methods, Compositions, And Kits Relating To Chitinases And Chitinase-Like Molecules And Inflammatory Disease
Methods, Compositions, And Kits Relating To Chitinases And Chitinase-Like Molecules And Inflammatory Disease
US Patent:
2009014, Jun 11, 2009
Filed:
Jul 18, 2008
Appl. No.:
12/218840
Inventors:
Jack A. Elias - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 33/34, A61K 31/7042, A61K 31/4353, A61K 33/30, A61P 29/00, A61K 33/28, A61K 38/12, A61K 31/525
US Classification:
424630, 514 27, 514279, 514 9, 514251, 424641, 424644
Abstract:
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g. asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic rhinitis, scleroderma, and the like), relating to inhibiting a chitinase-like molecule. The invention further includes methods to identify new compounds for the treatment of inflammatory disease, including, but not limited to, asthma, COPD and the like. This is because the present invention demonstrates, for the first time, that expression of IL-13, and of a chitinase-like molecule, mediates and/or is associated with inflammatory disease and that inhibiting the chitinase-like molecule treats and even prevents, the disease. Thus, the invention relates to the novel discovery that inhibiting a chitinase-like molecule treats and prevents an inflammatory disease.
Methods, Compositions And Kits Relating To Chitnases And Chitnase-Like Molecules And Inflammation Disease
Methods, Compositions And Kits Relating To Chitnases And Chitnase-Like Molecules And Inflammation Disease
US Patent:
2013013, May 30, 2013
Filed:
Jul 12, 2010
Appl. No.:
12/834650
Inventors:
Jack A. Elias - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
C07K 16/18, C07K 16/40
US Classification:
4241581
Abstract:
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g., asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic rhinitis, scleroderma, and the like), relating to inhibiting a chitinase-like molecule. The invention further includes methods to identify new compounds for the treatment of inflammatory disease, including, but not limited to, asthma, COPD and the like. This is because the present invention demonstrates, for the first time, that expression of IL-13, and of a chitinase-like molecule, mediates and/or is associated with inflammatory disease and that inhibiting the chitinase-like molecule treats and even prevents, the disease. Thus, the invention relates to the novel discovery that inhibiting a chitinase-like molecule treats and prevents an inflammatory disease.
Methods, Compositions, And Kits Relating To Chitinases And Chitinase-Like Molecules And Inflammatory Disease
Methods, Compositions, And Kits Relating To Chitinases And Chitinase-Like Molecules And Inflammatory Disease
US Patent:
2009014, Jun 11, 2009
Filed:
Jul 18, 2008
Appl. No.:
12/218836
Inventors:
Jack A. Elias - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Zhou Zhu - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 31/7052, A61P 29/00, A61P 11/06, A61P 9/00
US Classification:
514 44
Abstract:
The present invention includes compositions and methods for the treatment of inflammatory disease (e.g. asthma, COPD, inflammatory bowel disease, atopic dermatitis, atopy, allergy, allergic rhinitis, scleroderma, and the like), relating to inhibiting a chitinase-like molecule. The invention further includes methods to identify new compounds for the treatment of inflammatory disease, including, but not limited to, asthma, COPD and the like. This is because the present invention demonstrates, for the first time, that expression of IL-13, and of a chitinase-like molecule, mediates and/or is associated with inflammatory disease and that inhibiting the chitinase-like molecule treats and even prevents, the disease. Thus, the invention relates to the novel discovery that inhibiting a chitinase-like molecule treats and prevents an inflammatory disease.
Methods And Compositions Relating To Vascular Endothelial Growth Factor And Th2 Mediated Inflammatory Diseases
Methods And Compositions Relating To Vascular Endothelial Growth Factor And Th2 Mediated Inflammatory Diseases
US Patent:
2009015, Jun 18, 2009
Filed:
Jan 18, 2005
Appl. No.:
10/586254
Inventors:
Jack A. Elias - Woodbridge CT, US
Assignee:
YALE UNIVERSITY - New Haven CT
International Classification:
A61K 39/395, A61K 31/7052, A61K 38/02, A61P 29/00, A61K 38/43, G01N 33/68
US Classification:
4241341, 4241581, 514 44, 514 2, 424 941, 436 86, 435 29
Abstract:
The present invention includes compositions and methods for the treatment of a Th2 mediated inflammatory disease, relating to inhibiting a VEGF. The invention further includes methods to identify new compounds for the treatment of a Th2 mediated inflammatory disease, including, but not limited to, asthma and the like. This is because the present invention demonstrates, for the first time, that expression of VEGF induces asthma-like phenotype and that inhibiting VEGF reverses the phenotype. Thus, the invention relates to the novel discovery that inhibiting VEGF treats and prevents an Th2 mediated inflammatory disease.
Chitinase-3-Like Protein 1 As A Biomarker Of Recovery From Kidney Injury
Chitinase-3-Like Protein 1 As A Biomarker Of Recovery From Kidney Injury
US Patent:
2013003, Feb 7, 2013
Filed:
May 17, 2012
Appl. No.:
13/474011
Inventors:
Jack A. Elias - Woodbridge CT, US
Chirag R. Parikh - Wallingford CT, US
Lloyd G. Cantley - East Haven CT, US
Chirag R. Parikh - Wallingford CT, US
Lloyd G. Cantley - East Haven CT, US
International Classification:
G01N 33/566, A61P 13/12, A61K 38/17, C12Q 1/68, C40B 30/04
US Classification:
514 154, 436501, 435 71, 435 792, 435 611, 435 612, 506 9
Abstract:
The present invention provides compositions and methods for the detection, treatment, and prevention of a kidney injury. The invention relates to the discovery that chitinase 3-like 1/Brp-39/YKL-40 serves as both a biomarker for the degree of kidney injury and a critical mediator of a reparative response in the kidney.
Methods Of Treating Inflammatory Airway Conditions By Inhibition Of Il-11 Activity
Methods Of Treating Inflammatory Airway Conditions By Inhibition Of Il-11 Activity
US Patent:
8182814, May 22, 2012
Filed:
Oct 23, 2008
Appl. No.:
12/256883
Inventors:
Manuel Baca - Gaithersburg MD, US
Andrew Donald Nash - Kew, AU
Jack A. Elias - Woodbridge CT, US
Andrew Donald Nash - Kew, AU
Jack A. Elias - Woodbridge CT, US
Assignee:
CSL Limited - Parkville, Victoria
Yale University - New Haven CT
Yale University - New Haven CT
International Classification:
A61K 38/20, C07K 14/715, C07K 14/54, C07K 16/28, C07K 16/24
US Classification:
4241431, 4241331, 4241391, 4241411, 4241451, 530351, 5303873, 53038822, 53038823
Abstract:
The present invention provides a method for the treatment or prophylaxis of T-helper type 2 (Th2)-mediated disorders using antagonists of IL-11.
Compositions And Methods For Using Human Ykl-40 To Treat Acute Lung Injury
Compositions And Methods For Using Human Ykl-40 To Treat Acute Lung Injury
US Patent:
2013015, Jun 20, 2013
Filed:
Jun 16, 2011
Appl. No.:
13/704400
Inventors:
Jack A. Elias - Woodbridge CT, US
Assignee:
YALE UNIVERSITY - New Haven CT
International Classification:
A61K 38/47
US Classification:
424 9461, 435 18, 435 792
Abstract:
The invention includes methods of treating oxidant-mediated acute lung injury in a subject by administration of a chitinase-like protein molecule, or an activator thereof. The invention also includes methods of assessing the level of a chitinase-like protein molecule in a subject as a marker of the prognosis of a subject suffering from acute lung injury.
Methods And Compositions Relating To Ccr5 Antagonist, Ifn-Γ And Il-13 Induced Inflammation
Methods And Compositions Relating To Ccr5 Antagonist, Ifn-Γ And Il-13 Induced Inflammation
US Patent:
8221988, Jul 17, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084239
Inventors:
Bing Ma - Branford CT, US
Jack Elias - Woodbridge CT, US
Jack Elias - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
G01N 33/53, A61K 39/395
US Classification:
435 71, 4241301
Abstract:
The present invention includes compositions and methods for the treatment of Th1 and/or Th2 mediated inflammatory diseases, relating to inhibiting CCR5. This is because the present invention demonstrates, for the first time, that expression of IFN-γ, IL-13, and CCR5, mediates and/or is associated with Th1 and/or Th2 inflammatory diseases and that inhibiting CCR5 treats, and even prevents, the diseases. Thus, the invention relates to the novel discovery that inhibiting CCR5 treats and prevents Th1 and/or Th2 mediated inflammatory disease.